EC Number | Application | Comment | Organism |
---|---|---|---|
1.17.1.8 | medicine | - |
Escherichia coli |
1.17.1.8 | medicine | potential drug target in therapy of tuberculosis caused by resistent strains of Mycobacterium tuberculosis, molecular modeling for identification of potential inhibitors | Mycobacterium tuberculosis |
EC Number | Cloned (Comment) | Organism |
---|---|---|
1.17.1.8 | dapB gene, expression in Escherichia coli | Mycobacterium tuberculosis |
1.17.1.8 | dapB gene, overexpression from plasmid in Escherichia coli | Escherichia coli |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.17.1.8 | 2,6-pyridinedicarboxylic acid | - |
Escherichia coli | |
1.17.1.8 | 2,6-pyridinedicarboxylic acid | - |
Mycobacterium tuberculosis | |
1.17.1.8 | additional information | investigation of inhibitory potential of diverse heterocyclic and aromatic compounds, overview | Mycobacterium tuberculosis | |
1.17.1.8 | sulfonamide derivatives | - |
Mycobacterium tuberculosis |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.17.1.8 | 2,3-dihydrodipicolinate + NAD(P)H | Escherichia coli | - |
2,3,4,5-tetrahydrodipicolinate + NAD(P)+ | - |
? | |
1.17.1.8 | 2,3-dihydrodipicolinate + NAD(P)H | Mycobacterium tuberculosis | essentially involved in cell wall synthesis | 2,3,4,5-tetrahydrodipicolinate + NAD(P)+ | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.17.1.8 | Escherichia coli | P04036 | - |
- |
1.17.1.8 | Mycobacterium tuberculosis | - |
- |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
1.17.1.8 | overexpression in Escherichia coli from plasmid | Escherichia coli |
1.17.1.8 | recombinant enzyme expressed in Escherichia coli | Mycobacterium tuberculosis |
EC Number | Reaction | Comment | Organism | Reaction ID |
---|---|---|---|---|
1.17.1.8 | (S)-2,3,4,5-tetrahydropyridine-2,6-dicarboxylate + NAD(P)+ + H2O = (2S,4S)-4-hydroxy-2,3,4,5-tetrahydrodipicolinate + NAD(P)H + H+ | binding mechanism of diverse inhibitors | Mycobacterium tuberculosis |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.17.1.8 | 2,3-dihydrodipicolinate + NAD(P)H | - |
Mycobacterium tuberculosis | 2,3,4,5-tetrahydrodipicolinate + NAD(P)+ | - |
? | |
1.17.1.8 | 2,3-dihydrodipicolinate + NAD(P)H | - |
Escherichia coli | 2,3,4,5-tetrahydrodipicolinate + NAD(P)+ | - |
? | |
1.17.1.8 | 2,3-dihydrodipicolinate + NAD(P)H | essentially involved in cell wall synthesis | Mycobacterium tuberculosis | 2,3,4,5-tetrahydrodipicolinate + NAD(P)+ | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.17.1.8 | DHDP reductase | - |
Mycobacterium tuberculosis |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
1.17.1.8 | NADH | - |
Escherichia coli | |
1.17.1.8 | NADPH | - |
Mycobacterium tuberculosis | |
1.17.1.8 | NADPH | - |
Escherichia coli |